NeuroTherapia is a clinical stage company developing new treatments for neuroinflammatory disorders, focusing on small molecule therapies to treat central nervous system diseases
NeuroTherapia is a clinical stage company developing new treatments for neuroinflammatory disorders, focusing on small molecule therapies to treat central nervous system diseases. Their lead product, NTRX-07, is a cannabinoid type 2 receptor agonist that targets neuroinflammation in conditions like Alzheimer's disease.